NCT01888900View on ClinicalTrials.gov

New Treatment Response in People With and Without Cirrhosis From Chronic Hepatitis C

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
CirrhosisChronic Hepatitis CHepatitis CHepatitis C, Chronic
Interventions
DRUG

DUAL

Asunaprevir and Daclatsvir

DRUG

QUAD

Asunaprevir, daclatsvir, peginterferon and ribavirin

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

Sponsors

Collaborators (1)

Bristol-Myers Squibb
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH